Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India.
Department of Pathology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, 400012, India.
Biochem Biophys Res Commun. 2022 Jan 1;586:14-19. doi: 10.1016/j.bbrc.2021.11.071. Epub 2021 Nov 19.
Plakophilin3 (PKP3) loss leads to tumor progression and metastasis of colon cancer cells. The goal of this report was to determine if PKP3 loss led to increased disease progression in mice. We generated a colonocyte-specific knockout of PKP3 in APC mice, which led to increased adenoma formation, the formation of rectal prolapse, and a significant decrease in survival. The observed increase in rectal prolapse formation and decrease in survival correlated with an increase in the expression of Lipocalin2 (LCN2). Increased disease progression was observed even upon treatment with 5-fluorouracil (5FU). These results suggest that an increase in LCN2 expression might lead to therapy resistance and that LCN2 might serve as a potential therapeutic target in colorectal cancer.
桥粒斑蛋白 3(PKP3)缺失导致结肠癌细胞的肿瘤进展和转移。本报告的目的是确定 PKP3 缺失是否导致小鼠疾病进展加快。我们在 APC 小鼠中生成了结肠细胞特异性的 PKP3 敲除,这导致腺瘤形成增加、直肠脱垂形成、以及生存率显著降低。观察到的直肠脱垂形成增加和生存率降低与脂联素 2(LCN2)表达增加相关。即使在用 5-氟尿嘧啶(5FU)治疗后,也观察到疾病进展增加。这些结果表明,LCN2 表达的增加可能导致治疗耐药,并且 LCN2 可能是结直肠癌的潜在治疗靶点。